These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6285945)

  • 1. Effects of pindolol and propranolol on beta-adrenergic receptors on human lymphocytes.
    Molinoff PB; Aarons RD; Nies AS; Gerber JG; Wolfe BB; Goens MB
    Br J Clin Pharmacol; 1982; 13(Suppl 2):365S. PubMed ID: 6285945
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of drugs on beta-adrenergic receptors on human lymphocytes.
    Molinoff PB; Aarons RD
    J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S63-7. PubMed ID: 6188922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of pindolol and propranolol on beta adrenergic receptors on human lymphocytes.
    Hedberg A; Gerber JG; Nies AS; Wolfe BB; Molinoff PB
    J Pharmacol Exp Ther; 1986 Oct; 239(1):117-23. PubMed ID: 3020227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevation of beta-adrenergic receptor density in human lymphocytes after propranolol administration.
    Aarons RD; Nies AS; Gal J; Hegstrand LR; Molinoff PB
    J Clin Invest; 1980 May; 65(5):949-57. PubMed ID: 6102572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of beta-adrenoceptors in the guinea pig.
    Bertholet A; Milavec M; Waite R
    Postgrad Med J; 1981; 57 Suppl 1():9-17. PubMed ID: 6272256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of changes in the characteristics of beta-adrenoceptors and responsiveness of human circulating lymphocytes during and after chronic administration of pindolol and propranolol.
    Giudicelli Y; Lacasa D; Agli B; Leneveu A
    Eur J Clin Pharmacol; 1984; 26(1):7-12. PubMed ID: 6325205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of propranolol and pindolol on the up-regulation of lymphocytic beta adrenoceptors during acute submaximal physical exercise. A placebo-controlled double-blind study.
    Mäki T; Näveri H; Leinonen H; Sovijärvi A; Lewko B; Härkönen M; Kontula K
    J Cardiovasc Pharmacol; 1990 Apr; 15(4):544-51. PubMed ID: 1691382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased human lymphocyte beta-adrenergic receptor density following chronic propranolol treatment.
    Aarons RD; Nies AS; Gal J; Molinoff PB
    Proc West Pharmacol Soc; 1979; 22():175-6. PubMed ID: 229487
    [No Abstract]   [Full Text] [Related]  

  • 9. Changes in the density of beta adrenergic receptors in rat lymphocytes, heart and lung after chronic treatment with propranolol.
    Aarons RD; Molinoff PB
    J Pharmacol Exp Ther; 1982 May; 221(2):439-43. PubMed ID: 6281414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-2-blocking effect of metoprolol.
    Conolly ME
    N Engl J Med; 1979 Apr; 300(15):864-5. PubMed ID: 34099
    [No Abstract]   [Full Text] [Related]  

  • 11. [Relationship between the blood level and the inhibitory effect of renin activation under beta-receptor blockade using pindolol].
    Höffgen KU; Laudage G; von Lilienfeld-Toal H; Gugler R; Bodem G
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1337-9. PubMed ID: 197733
    [No Abstract]   [Full Text] [Related]  

  • 12. Selective increases in the density of cerebellar beta-1-adrenergic receptors.
    Wolfe BB; Minneman KP; Molinoff PB
    Brain Res; 1982 Feb; 234(2):474-9. PubMed ID: 6277437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The response of lymphocyte beta-adrenergic receptors to chronic propranolol treatment in depressed patients, schizophrenic patients, and normal controls.
    Zohar J; Bannet J; Drummer D; Fisch R; Epstein RP; Belmaker RH
    Biol Psychiatry; 1983 May; 18(5):553-60. PubMed ID: 6305430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of beta-blockade and the non-specific effect of bucumolol, a beta-adrenergic blocking agent, on atrioventricular conduction in anesthetized dogs.
    Nakayama K; Oshima T; Koike H
    Arch Int Pharmacodyn Ther; 1981 Nov; 254(1):145-56. PubMed ID: 6121536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of adrenoreceptor stimulation on in vitro spontaneous lymphocyte adhesion].
    Kharkevich DD
    Biull Eksp Biol Med; 1989 Jan; 107(1):54-6. PubMed ID: 2536570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Decrease in maximum consumption of oxygen after blockage of beta-andrenergic receptors].
    Scheen A; Juchmès J; Lennes G; Lecomte J
    Arch Int Physiol Biochim; 1976 Dec; 84(5):915-23. PubMed ID: 66035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased shock-induced fighting with supersensitive beta-adrenergic receptors.
    Hegstrand LR; Eichelman B
    Pharmacol Biochem Behav; 1983 Aug; 19(2):313-20. PubMed ID: 6314390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison between the influence of pindolol and propranolol on the response of plasma potassium to catecholamines.
    Castro-Tavares J
    Arzneimittelforschung; 1976 Feb; 26(2):238-41. PubMed ID: 947205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Modification of the cardiovascular-dynamic effect of Akrinor following the blockade of adrenergic beta receptors with propranolol].
    Sternitzke N; Schieffer H; Hoffmann W; Bette L
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1132-5. PubMed ID: 197729
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of treatment with pindolol, acebutolol and propranolol on the density of beta-adrenergic receptors in human lymphocytes].
    Halawa B
    Pol Tyg Lek; 1987 Feb; 42(6):153-5. PubMed ID: 3037504
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.